449 related articles for article (PubMed ID: 30597038)
1. C-C chemokine receptor type 2 mediates glomerular injury and interstitial fibrosis in focal segmental glomerulosclerosis.
Wilkening A; Krappe J; Mühe AM; Lindenmeyer MT; Eltrich N; Luckow B; Vielhauer V
Nephrol Dial Transplant; 2020 Feb; 35(2):227-239. PubMed ID: 30597038
[TBL] [Abstract][Full Text] [Related]
2. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome.
Vielhauer V; Berning E; Eis V; Kretzler M; Segerer S; Strutz F; Horuk R; Gröne HJ; Schlöndorff D; Anders HJ
Kidney Int; 2004 Dec; 66(6):2264-78. PubMed ID: 15569315
[TBL] [Abstract][Full Text] [Related]
3. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS
Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709
[TBL] [Abstract][Full Text] [Related]
4. Tubular GM-CSF Promotes Late MCP-1/CCR2-Mediated Fibrosis and Inflammation after Ischemia/Reperfusion Injury.
Xu L; Sharkey D; Cantley LG
J Am Soc Nephrol; 2019 Oct; 30(10):1825-1840. PubMed ID: 31315923
[TBL] [Abstract][Full Text] [Related]
5. Podocyte injury-driven lipid peroxidation accelerates the infiltration of glomerular foam cells in focal segmental glomerulosclerosis.
Hara S; Kobayashi N; Sakamoto K; Ueno T; Manabe S; Takashima Y; Hamada J; Pastan I; Fukamizu A; Matsusaka T; Nagata M
Am J Pathol; 2015 Aug; 185(8):2118-31. PubMed ID: 26072030
[TBL] [Abstract][Full Text] [Related]
6. CCR2 antagonism leads to marked reduction in proteinuria and glomerular injury in murine models of focal segmental glomerulosclerosis (FSGS).
Miao Z; Ertl LS; Newland D; Zhao B; Wang Y; Zang X; Campbell JJ; Liu X; Dang T; Miao S; Krasinski A; Punna S; Zeng Y; McMahon J; Zhang P; Charo IF; Schall TJ; Singh R
PLoS One; 2018; 13(3):e0192405. PubMed ID: 29561839
[TBL] [Abstract][Full Text] [Related]
7. HIV-associated nephropathy: experimental models.
Avila-Casado C; Fortoul TI; Chugh SS
Contrib Nephrol; 2011; 169():270-285. PubMed ID: 21252526
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin as an injury marker expressing in epithelial hyperplasia lesions helpful in prognosis of focal segmental glomerulosclerosis.
Shui HA; Ka SM; Yang SM; Lin YF; Lo YF; Chen A
Transl Res; 2007 Oct; 150(4):216-22. PubMed ID: 17900509
[TBL] [Abstract][Full Text] [Related]
9. Monocytes expressing activin A and CCR2 exacerbate chronic testicular inflammation by promoting immune cell infiltration.
Hasan H; Peng W; Wijayarathna R; Wahle E; Fietz D; Bhushan S; Pleuger C; Planinić A; Günther S; Loveland KL; Pilatz A; Ježek D; Schuppe HC; Meinhardt A; Hedger MP; Fijak M
Hum Reprod; 2024 May; ():. PubMed ID: 38775335
[TBL] [Abstract][Full Text] [Related]
10. Combined inhibition of CCR2 and ACE provides added protection against progression of diabetic nephropathy in
Tesch GH; Pullen N; Jesson MI; Schlerman FJ; Nikolic-Paterson DJ
Am J Physiol Renal Physiol; 2019 Dec; 317(6):F1439-F1449. PubMed ID: 31566438
[TBL] [Abstract][Full Text] [Related]
11. miR-150 inhibitor ameliorates adriamycin-induced focal segmental glomerulosclerosis.
Qi H; Fu J; Luan J; Jiao C; Cui X; Cao X; Zhang Y; Wang Y; Kopp JB; Pi J; Zhou H
Biochem Biophys Res Commun; 2020 Feb; 522(3):618-625. PubMed ID: 31787235
[TBL] [Abstract][Full Text] [Related]
12. Role of C/EBP-α in Adriamycin-induced podocyte injury.
Zhong F; Wang W; Lee K; He JC; Chen N
Sci Rep; 2016 Sep; 6():33520. PubMed ID: 27644413
[TBL] [Abstract][Full Text] [Related]
13. Astaxanthin attenuates adriamycin-induced focal segmental glomerulosclerosis.
Liu G; Shi Y; Peng X; Liu H; Peng Y; He L
Pharmacology; 2015; 95(3-4):193-200. PubMed ID: 25924598
[TBL] [Abstract][Full Text] [Related]
14. Role of CD8(+) cells in the progression of murine adriamycin nephropathy.
Wang Y; Wang YP; Tay YC; Harris DC
Kidney Int; 2001 Mar; 59(3):941-9. PubMed ID: 11231349
[TBL] [Abstract][Full Text] [Related]
15. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A
Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525
[TBL] [Abstract][Full Text] [Related]
16. The atypical chemokine receptor 2 limits renal inflammation and fibrosis in murine progressive immune complex glomerulonephritis.
Bideak A; Blaut A; Hoppe JM; Müller MB; Federico G; Eltrich N; Gröne HJ; Locati M; Vielhauer V
Kidney Int; 2018 Apr; 93(4):826-841. PubMed ID: 29395335
[TBL] [Abstract][Full Text] [Related]
17. Rapamycin attenuates the severity of murine adriamycin nephropathy.
Lui SL; Tsang R; Chan KW; Zhang F; Tam S; Yung S; Chan TM
Am J Nephrol; 2009; 29(4):342-52. PubMed ID: 18948688
[TBL] [Abstract][Full Text] [Related]
18. CD44 is required for the pathogenesis of experimental crescentic glomerulonephritis and collapsing focal segmental glomerulosclerosis.
Eymael J; Sharma S; Loeven MA; Wetzels JF; Mooren F; Florquin S; Deegens JK; Willemsen BK; Sharma V; van Kuppevelt TH; Bakker MA; Ostendorf T; Moeller MJ; Dijkman HB; Smeets B; van der Vlag J
Kidney Int; 2018 Mar; 93(3):626-642. PubMed ID: 29276101
[TBL] [Abstract][Full Text] [Related]
19. Role of fibroblast specific protein 1 expression in the progression of adriamycin-induced glomerulosclerosis.
Nakatani K; Asai O; Konishi N; Iwano M
Biochem Biophys Res Commun; 2021 Aug; 567():148-153. PubMed ID: 34153685
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of CD44-positive glomerular parietal epithelial cells reflects podocyte injury in adriamycin nephropathy.
Okamoto T; Sasaki S; Yamazaki T; Sato Y; Ito H; Ariga T
Nephron Exp Nephrol; 2013; 124(3-4):11-8. PubMed ID: 24401840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
